tiprankstipranks
Trending News
More News >
Zurich Insurance Group AG (ZURVY)
OTHER OTC:ZURVY
US Market

Zurich Insurance Group AG (ZURVY) Stock Forecast & Price Target

Compare
144 Followers
See the Price Targets and Ratings of:

ZURVY Financial Forecast

ZURVY Earnings Forecast

Next quarter’s earnings estimate for ZURVY is $1.09 with a range of $1.09 to $1.09. The previous quarter’s EPS was $0.97. ZURVY beat its EPS estimate 100.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 56.00% of the time in the same period. In the last calendar year ZURVY has Outperformed its overall industry.
Next quarter’s earnings estimate for ZURVY is $1.09 with a range of $1.09 to $1.09. The previous quarter’s EPS was $0.97. ZURVY beat its EPS estimate 100.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 56.00% of the time in the same period. In the last calendar year ZURVY has Outperformed its overall industry.

ZURVY Sales Forecast

Next quarter’s sales forecast for ZURVY is $22.84B with a range of $22.84B to $22.84B. The previous quarter’s sales results were $41.68B. ZURVY beat its sales estimates 100.00% of the time in past 12 months, while its overall industry beat sales estimates 77.45% of the time in the same period. In the last calendar year ZURVY has Outperformed its overall industry.
Next quarter’s sales forecast for ZURVY is $22.84B with a range of $22.84B to $22.84B. The previous quarter’s sales results were $41.68B. ZURVY beat its sales estimates 100.00% of the time in past 12 months, while its overall industry beat sales estimates 77.45% of the time in the same period. In the last calendar year ZURVY has Outperformed its overall industry.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Exane BNP Paribas
Sell
Downgraded
10/03/24
Zurich Insurance downgraded to Underperform from Neutral at Exane BNP ParibasZurich Insurance downgraded to Underperform from Neutral at Exane BNP Paribas
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Exane BNP Paribas
Sell
Downgraded
10/03/24
Zurich Insurance downgraded to Underperform from Neutral at Exane BNP ParibasZurich Insurance downgraded to Underperform from Neutral at Exane BNP Paribas
Stocks with the Highest Top Analyst Consensus in the Financial Sector
Find stocks in the Financial sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Zurich Insurance Group AG

Which Analyst Should I Follow If I Want to Buy ZURVY and Sell After:
1 Month
xxx
Success Rate
0/1 ratings generated profit
0%
Average Return
-0.10%
downgraded a xxx
rating 6 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 0.00% of your transactions generating a profit, with an average return of -0.10% per trade.
3 Months
xxx
Success Rate
0/1 ratings generated profit
0%
Average Return
-1.10%
downgraded a xxx
rating 6 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 0.00% of your transactions generating a profit, with an average return of -1.10% per trade.
1 Year
Dominic O'MahonyExane BNP Paribas
Success Rate
0/1 ratings generated profit
0%
Average Return
-9.60%
downgraded a sell rating 6 months ago
Copying Dominic O'Mahony's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -9.60% per trade.
2 Years
xxx
Success Rate
0/1 ratings generated profit
0%
Average Return
-9.60%
downgraded a xxx
rating 6 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 0.00% of your transactions generating a profit, with an average return of -9.60% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

ZURVY Analyst Recommendation Trends

Rating
May 19
Jun 19
Jan 21
Feb 24
Oct 24
Strong Buy
0
0
0
0
0
Buy
1
1
1
2
1
Hold
2
2
2
1
1
Sell
0
0
0
0
1
Strong Sell
0
0
0
0
0
total
3
3
3
3
3
In the current month, ZURVY has received 1 Buy Ratings, 1 Hold Ratings, and 1 Sell Ratings. ZURVY average Analyst price target in the past 3 months is .
Each month's total comprises the sum of three months' worth of ratings.

ZURVY Stock Forecast FAQ

What is ZURVY’s average 12-month price target, according to analysts?
Currently, no data Available
What is ZURVY’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for ZURVY, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
    How can I follow the stock ratings of top Wall Street analysts?
    Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
      Is ZURVY a Buy, Sell or Hold?
      Currently, no data Available
      What is Zurich Insurance Group AG’s price target?
      Currently, no data Available
      What do analysts say about Zurich Insurance Group AG?
      Not enough analysts have published a price target to provide an average price target.
      How can I buy shares of ZURVY?
      Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.
        What am I Missing?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis